Showing 161-170 of 4164 results for "".
20. Seeing Double? We Don't Want Any Trouble!
https://modernod.com/podcasts/four-eyes/20-seeing-double-we-dont-want-any-trouble/36970/We share tips on how to approach monocular and binocular double vision. Amrit also shares experience from her VT residency to highlight important case history questions and various binocular testing you can perform in a primary care setting to help identify the cause.Resources:1. Covalent Careers ArOSD Diagnostic Tests I Can’t Practice Without
https://modernod.com/topics/ocular-surface/osd-diagnostic-tests-i-cant-practice-without/39177/The author discusses two platforms he feels are vital to his clinical evaluation of ocular surface disease.Always New Opportunities to Grow and Learn
https://modernod.com/topics/business/always-new-opportunities-to-grow-and-learn/38051/Persistent Fetal Vasculature
https://modernod.com/topics/patient-care/persistent-fetal-vasculature/38999/Diagnosis can be challenging. Management is based on the patient’s visual potential.New Treatments for Diabetic Eye Disease
https://modernod.com/topics/retina/new-treatments-for-diabetic-eye-disease/38894/A rundown of the latest therapy options in clinical trials—and a few in earlier developmental stages.3. Soft Contact Lens Showdown!
https://modernod.com/podcasts/four-eyes/3-soft-contact-lens-showdown/36953/We have a showdown of our favourite soft contact lenses and share info on Mojo Vision’s augmented reality contact lenses.Resources:1. Modern OD Article on What's New in Contact Lenses: https://modernod.com/articles/2019-nov-dec/whats-new-in-contact-lenses?c4src=article:infinite-scroll2. New CanadianThe Role of Oculoplastics in Optometry
https://modernod.com/topics/ocular-surface/the-role-of-oculoplastics-in-optometry/38983/Take advantage of the clinical opportunities afforded by adopting an ocular aesthetics perspective.Harrow Adds Biosimilars to US Portfolio
https://modernod.com/podcasts/eyewire-news-the-podcast/harrow-adds-biosimilars-to-us-portfolio/37094/Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoicesFDA Approves First Treatment for MacTel
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-approves-first-treatment-for-mactel/37075/The CEO of Neurotech joins us to talk about the FDA approval of the first treatment for MacTel; a target action date is set for Sydnexis’ pediatric myopia treatment candidate; and three eye care companies collaborate to launch a wearable vision testing platform. Learn more about your ad choices. VisGenetic Testing's Role in Myopia Management
https://modernod.com/podcasts/the-mod-pod/genetic-testings-role-in-myopia-management/36828/John D. Gelles, OD, FIAO, FCLSA, FSLS, FBCLA, talks with guest Melissa Barnett, OD, FAAO, FSLS, FBCLA, about how AvaGen, The Genetic Eye Test, for keratoconus and corneal dystrophies can guide one's myopia management decisions and potentially help save vision for patients over their lifetime.